Elsevier

The Lancet

Volume 343, Issue 8889, 8 January 1994, Pages 83-84
The Lancet

Cancer mortality in chronic typhoid and paratyphoid carriers

https://doi.org/10.1016/S0140-6736(94)90816-8Get rights and content

Abstract

It has been shown in vitro that bacteria are able to form or release carcinogens, mutagens, or promoters from intestinal secretions such as bile, or from excretions such as urine. It is, therefore, of interest to find out whether chronic infection of the gallbladder is associated with carcinogens, as in chronic infection of the urinary bladder. A study of cancer risk in chronic typhoid and paratyphoid carriers showed a large excess (observed/expected cases) for cancer of the gallbladder (167·0; 95% confidence interval 54·1-389) and also excess risks of cancer of the pancreas (8·1), colorectum (3·0), lung (2·5), and all neoplasms (2 6). There was no similar excess risk in a group of 386 people with typhoid from the 1964 Aberdeen outbreak. This indicates that it is long-term typhoid carriage, not acute infection, which is the risk factor. This has important implications for cancer prevention. Eradication of chronic carriage, by use of antibiotics or elective cholecystectomy, should be re-emphasised, and the need for good documentation of carriers is, therefore, of great importance.

References (13)

There are more references available in the full text version of this article.

Cited by (169)

  • Germline Genetic Associations for Hepatobiliary Cancers

    2024, Cellular and Molecular Gastroenterology and Hepatology
  • Diseases of the Gallbladder

    2023, MacSween's Pathology of the Liver, Eighth Edition
  • Microbial Diversity and Classification

    2022, Encyclopedia of Infection and Immunity
  • Molecular modelling of the gastric barrier response, from infection to carcinogenesis

    2021, Best Practice and Research: Clinical Gastroenterology
  • Microbiome changes in aging

    2021, Handbook of the Biology of Aging
View all citing articles on Scopus
View full text